常染色体显性多囊肾病慢性难治性疼痛的多学科管理
该研究分析了多学科方案治疗常染色体显性多囊肾病(ADPKD)慢性难治性疼痛的长期疗效,方案依次包括镇痛药、囊肿穿刺抽液与开窗、神经阻滞及肾切除术。共评估101例患者,治疗后总体76.9%疼痛获得积极效果,视觉模拟量表(VAS)评分从60/100降至20/100(P < 0.001),中位随访4.5年后69.0%的患者仍有较少疼痛主诉。
要点
- 多学科方案治疗后76.9%患者疼痛短期获积极效果,VAS评分由60/100降至20/100(P < 0.001)。
- 中位随访4.5年(四分位距2.5-5.3)后,69.0%患者仍有较少疼痛主诉。
- 最终仅13例(12.9%)需手术干预,包括11例肾切除术。
核心结论
- 多学科治疗方案似乎对多数慢性难治性疼痛的ADPKD患者有效减轻疼痛,同时在多数患者中推迟甚至避免肾切除术等手术干预。
研究设计与样本
- 单中心临床分析,评估该中心创新的多学科方案治疗ADPKD慢性难治性疼痛的长期疗效。
- 纳入标准:疼痛持续≥3个月且VAS评分≥50/100,对生活质量有负面影响,既往治疗(包括阿片类药物)反应不足。
- 共评估101例患者,平均年龄50 ± 11岁,65.3%为女性。
- 治疗选择依次为镇痛药、囊肿穿刺抽液与开窗、神经阻滞和肾切除术。
主要发现
- 8例患者接受药物治疗,6例接受囊肿穿刺抽液或开窗,63例接受神经阻滞,6例以手术作为首选治疗。
- 治疗后总体76.9%的患者疼痛主诉获得积极效果。
- VAS评分从60/100降至20/100(P < 0.001)。
- 非阿片类和阿片类镇痛药数量均显著减少(P < 0.001,P = 0.01)。
- 大量患者(n = 51)需要额外治疗;随访结束时仅13例(12.9%)需手术干预:11例肾切除术(其中10例已在肾脏功能替代治疗中),1例肝移植和1例部分肝切除术。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic pain is often difficult to manage in autosomal dominant polycystic kidney disease (ADPKD) patients and sometimes even leads to nephrectomy. We analyzed the long-term efficacy of our innovative multidisciplinary protocol to treat chronic refractory pain that aims to preserve kidney function by applying among other sequential nerve blocks. METHODS: Patients were eligible if pain was present ≥3 months with a score of ≥50 on a visual analog scale (VAS) of 100, was negatively affecting quality of life and if there had been insufficient response to previous therapies, including opioid treatment. Treatment options were, in order, analgesics, cyst aspiration and fenestration, nerve blocks and nephrectomy. RESULTS: A total of 101 patients were assessed in our clinic (mean age 50 ± 11 years, 65.3% females). Eight patients were treated with medication, 6 by cyst aspiration or fenestration, 63 by nerve blocks and 6 received surgery as the first treatment option. Overall, 76.9% experienced a positive effect on pain complaints shortly after treatment. The VAS score was reduced from 60/100 to 20/100 (P < 0.001) and patients decreased their number of nonopioid and opioid analgesics significantly (P < 0.001, P = 0.01, respectively). A substantial number of the patients (n = 51) needed additional treatment. At the end of follow-up in only 13 patients (12.9%) was surgical intervention necessary: 11 nephrectomies (of which 10 were in patients already on kidney function replacement treatment), 1 liver transplantation and 1 partial hepatectomy. After a median follow-up of 4.5 years (interquartile range 2.5-5.3), 69.0% of the patients still had fewer pain complaints. CONCLUSIONS: These data indicate that our multidisciplinary treatment protocol appears effective in reducing pain in the majority of patients with chronic refractory pain, while postponing or even avoiding in most patients surgical interventions such as nephrectomy in most patients.
引用
- van Luijk F, Gansevoort RT, Blokzijl H, et al. Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2023. PMID: 35512573. doi:10.1093/ndt/gfac158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。